Download PDF
Psychother Psychosom Med Psychol 2005; 55(1): 5-19
DOI: 10.1055/s-2004-834552
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Lernpsychologische Aspekte in der Psychoneuroimmunologie (PNI)

Conditioning Mechanisms and PsychoneuroimmunologyUrsula  Stockhorst1 , Sibylle  Klosterhalfen1
  • 1Institut für Medizinische Psychologie, Heinrich-Heine-Universität Düsseldorf
Further Information

Publication History

Eingegangen: 12. November 2003

Angenommen: 25. Juli 2004

Publication Date:
25 November 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Im vorliegenden Beitrag werden die lernpsychologischen Aspekte der Psychoneuroimmunologie (PNI) dargestellt. Dazu werden zunächst die relevanten lernpsychologischen Paradigmen beschrieben und Immunparameter klassifiziert (Kapitel 1). Lernpsychologische Aspekte in der PNI stützen sich maßgeblich auf das Paradigma der klassischen Konditionierung (KK), weniger auf die instrumentelle Konditionierung. Es werden deshalb zunächst Studien zur KK von Immunparametern vorgestellt und systematisiert, wobei vor allem tierexperimentelle Studien vorliegen (Kapitel 2). Im Hinblick auf die Relevanz der konditionierten Immunmodulation werden klinische Anwendungen der KK berichtet und am Beispiel einer Studie unserer Arbeitsgruppe zur antizipatorischen Immunmodulation bei pädiatrischen Chemotherapiepatienten vertieft (Kapitel 3). Annahmen zur Mediierung der konditionierten Immunmodulation werden zusammengefasst (Kapitel 4). Es wird auch gezeigt (Kapitel 5), inwieweit Kontingenzen der instrumentellen Konditionierung für die Immunmodulation relevant sind. Abschließend werden weitere Forschungsperspektiven aufgezeigt (Kapitel 6).

Abstract

This chapter deals with the role of conditioning principles in psychoneuroimmunology (PNI). We will first describe the paradigms of classical and instrumental conditioning and classify immune parameters that are subject to conditioning (chapter 1). So far, PNI research mainly uses classical (or Pavlovian) conditioning. We will summarize some of the paradigmatic studies, mainly animal studies (chapter 2) and also describe studies that support the clinical relevance of classical conditioning, i. e., in the pharmacological treatment of autoimmune diseases, transplantation and tumor chemotherapy (chapter 3). A study of our group on anticipatory immunomodulation in pediatric cancer patients is reported. Mechanisms mediating conditioned immunomodulation are summarized (chapter 4). We also describe studies that analyze the impact of instrumental conditioning contingencies on immune functioning (chapter 5). Finally, research perspectives are summarized (chapter 6).

Key words

Classical conditioning - instrumental conditioning - immunomodulation - CNS

Literatur

  • 1 Klosterhalfen S, Klosterhalfen W. The conditioning of immunopharmacological effects: Critical remarks and perspectives. In: Husband AJ (ed) Psychoimmunology, CNS-immune interactions. Boca Raton; CRC Press 1993: 149-162
    Google Scholar
  • 2 Ramsay D S, Woods S C. Biological consequences of drug administration: Implications for acute and chronic tolerance.  Psychol Rev. 1997;  104 170-193
    PubMedGoogle Scholar
  • 3 Ader R, Cohen N. The influence of conditioning on immune responses. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. San Diego; Academic Press 1991: 611-646
    Google Scholar
  • 4 Solvason H B, Ghanta V K, Hiramoto R N. The identity of the unconditioned stimulus to the central nervous system is interferon-β.  J Neuroimmunol. 1993;  45 75-82
    CrossrefPubMedGoogle Scholar
  • 5 Turnbull A V, Rivier C. Regulation of the HPA axis by cytokines.  Brain Behav Immun. 1995;  9 253-275
    CrossrefPubMedGoogle Scholar
  • 6 Maier S F, Watkins L R. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.  Psychol Rev. 1998;  105 83-107
    CrossrefPubMedGoogle Scholar
  • 7 Metal'nikov S, Chorine V. Rôle des reflexes conditionnels dans l'immunitée.  Ann Inst Pasteur (Paris). 1926;  40 893-900
    PubMedGoogle Scholar
  • 8 Spector N H. Konditionierung von Immunreaktionen. In: Kaschka WP, Aschauer HN (Hrsg) Psychoimmunologie. Stuttgart; Thieme 1990: 43-50
    Google Scholar
  • 9 Ader R, Cohen N. Behaviorally conditioned immunosuppression.  Psychosom Med. 1975;  37 333-340
    PubMedGoogle Scholar
  • 10 Overmier J B, Seligman M EP. Effects of inescapable shock upon subsequent escape and avoidance responding.  J Comp Physiol Psychol. 1967;  63 28-33
    PubMedGoogle Scholar
  • 11 Janeway C A, Travers P, Walport M, Shlomchick M. Immunologie. Heidelberg; Spektrum Akademischer Verlag 2002
    Google Scholar
  • 12 Schulz K-H, Schedlowski M, Schulz H, Kugler J. Struktur und Funktion des Immunsystems - Eine kurze Einführung.  Z Med Psychol. 1997;  2 53-58
    PubMedGoogle Scholar
  • 13 Segerstrom S C, Miller G E. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry.  Psych Bull. 2004;  130 601-630
    PubMedGoogle Scholar
  • 14 Herberman R B, Ortaldo J R. Natural killer cells: Their role in defenses against disease.  Science. 1981;  214 24-30
    CrossrefPubMedGoogle Scholar
  • 15 Ader R, Cohen N. Psychoneuroimmunology: Conditioning and stress.  Annu Rev Psychol. 1993;  44 53-85
    CrossrefPubMedGoogle Scholar
  • 16 Ader R. Letter to the editor.  Psychosom Med. 1974;  36 183-184
    PubMedGoogle Scholar
  • 17 Garcia J, Kimeldorf D J, Koelling R A. Conditioned aversion to saccharin resulting from exposure to gamma radiation.  Science. 1955;  122 157-158
    PubMedGoogle Scholar
  • 18 Klosterhalfen S, Klosterhalfen W. Conditioned taste aversion and traditional learning.  Psychol Res. 1985;  47 71-94
    CrossrefPubMedGoogle Scholar
  • 19 Klosterhalfen S, Klosterhalfen W. Classically conditioned effects of cyclophosphamide on white blood cell counts in rats.  Ann N Y Acad Sci. 1987;  496 569-577
    PubMedGoogle Scholar
  • 20 Roudebush R E, Bryant H U. Conditioned immunosuppression of a murine delayed type hypersensitivity response: Dissociation from corticosterone elevation.  Brain Behav Immun. 1991;  5 308-317
    CrossrefPubMedGoogle Scholar
  • 21 Exton M S, Hörsten S von, Schult M. et al . Behaviorally conditioned immunosuppression using cyclosporine A: Central nervous system reduces IL-2 production via splenic innervation.  J Neuroimmunol. 1998;  88 182-191
    CrossrefPubMedGoogle Scholar
  • 22 Stockhorst U, Spennes-Saleh S, Körholz D. et al . Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response?.  Brain Behav Immun. 2000;  14 198-218
    CrossrefPubMedGoogle Scholar
  • 23 Longo D L, Duffey P L, Kopp W C. et al . Conditioned immune response to interferon-γ in humans.  Clin Immunol. 1999;  90 173-181
    CrossrefPubMedGoogle Scholar
  • 24 Rogers M P, Reich P, Strom T B, Carpenter C B. Behaviorally conditioned immunosuppression: Replication of a recent study.  Psychosom Med. 1976;  38 447-451
    PubMedGoogle Scholar
  • 25 Napolitano F, Rosa G de, Grasso F. et al . Conditioned inhibition of antibody response and CD4 positive cells.  Physiol Behav. 1998;  64 395-398
    CrossrefPubMedGoogle Scholar
  • 26 Morato E F, Gerbase-DeLima M, Gorczynski R M. Conditioned immunosuppression in orally immunized mice.  Brain Behav Immun. 1996;  10 44-54
    CrossrefPubMedGoogle Scholar
  • 27 Djuric V J, Bienenstock J. Learned sensitivity.  Ann Allergy. 1993;  71 5-15
    PubMedGoogle Scholar
  • 28 Russell M, Dark K A, Cummins R W. et al . Learned histamine release.  Science. 1984;  225 733-734
    PubMedGoogle Scholar
  • 29 MacQueen G, Marshall J, Perdue M. et al . Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II.  Science. 1989;  243 83-85
    PubMedGoogle Scholar
  • 30 Ader R, Kelly K, Moynihan J A. et al . Conditioned enhancement of antibody production using antigen as the unconditioned stimulus.  Brain Behav Immun. 1993;  7 334-343
    CrossrefPubMedGoogle Scholar
  • 31 Alvarez-Borda B, Ramírez-Amaya V, Pérez-Montfort R, Bermúdez-Rattoni F. Enhancement of antibody production by a learning paradigm.  Neurobiol Learn Mem. 1995;  64 103-105
    CrossrefPubMedGoogle Scholar
  • 32 MacKenzie J N. The production of the so-called „rose cold” by means of an artificial rose.  Am J Med Sci. 1886;  91 45-57
    PubMedGoogle Scholar
  • 33 Dekker E, Groen J. Reproducible psychogenic attacks of asthma.  J Psychosom Res. 1956;  1 58-67
    CrossrefPubMedGoogle Scholar
  • 34 Dekker E, Pelser H E, Groen J. Conditioning as a cause of asthmatic attacks.  J Psychosom Res. 1957;  2 97-108
    CrossrefPubMedGoogle Scholar
  • 35 Gauci M, Husband A J, Saxarra H, King M G. Pavlovian conditioning of allergic rhinitis in humans. In: Husband AJ (ed) Psychoimmunology, CNS-immune interactions. Boca Raton; CRC Press 1993: 121-125
    Google Scholar
  • 36 Booth R J, Petrie K J, Brook R J. Conditioning allergic skin responses in humans: A controlled trial.  Psychosom Med. 1995;  57 492-495
    PubMedGoogle Scholar
  • 37 Cohen N, Ader R, Green N, Bovbjerg D. Conditioned suppression of a thymus-independent antibody response.  Psychosom Med. 1979;  41 487-491
    PubMedGoogle Scholar
  • 38 O'Reilly C A, Exon J H. Cyclophosphamide-conditioned suppression of the natural killer cell response in rats.  Physiol Behav. 1986;  37 759-764
    CrossrefPubMedGoogle Scholar
  • 39 Janz L J, Green-Johnson J, Murray L. et al . Pavlovian conditioning of LPS-induced responses: Effects on corticosterone, splenic NE and IL-2 production.  Physiol Behav. 1996;  59 1103-1109
    CrossrefPubMedGoogle Scholar
  • 40 Dyck D G, Janz L, Osachuk T AG. et al . The Pavlovian conditioning of IL-1 induced glucocorticoid secretion.  Brain Behav Immun. 1990;  4 93-104
    CrossrefPubMedGoogle Scholar
  • 41 Bovbjerg D. Interleukin 1 induces taste aversion as well as decreased food and water consumption in mice.  Psychosom Med. 1988;  50 196
    PubMedGoogle Scholar
  • 42 Goebel U, Trebst A, Steiner J. et al . Behavioral conditioning of immunosuppression is possible in humans.  FASEB J. 2002;  16 1869-1873
    CrossrefPubMedGoogle Scholar
  • 43 Bovbjerg D, Cohen N, Ader R. Behaviorally conditioned enhancement of delayed-type hypersensitivity in the mouse.  Brain Behav Immun. 1987;  1 64-71
    CrossrefPubMedGoogle Scholar
  • 44 Smith G R, McDaniel S M. Psychologically mediated effect on the delayed hypersensitivity reaction to tuberculin in humans.  Psychosom Med. 1983;  45 65-70
    PubMedGoogle Scholar
  • 45 Coussons M E, Dykstra L A, Lysle D T. Pavlovian conditioning of morphine-induced alterations of immune status.  J Neuroimmunol. 1992;  39 219-230
    CrossrefPubMedGoogle Scholar
  • 46 Buske-Kirschbaum A, Kirschbaum C, Stierle H. et al . Conditioned manipulation of natural killer (NK) cells in humans using a discriminative learning protocol.  Biol Psychol. 1994;  38 143-155
    CrossrefPubMedGoogle Scholar
  • 47 Buske-Kirschbaum A, Kirschbaum C, Stierle H. et al . Conditioned increase of natural killer cell activity (NKCA) in humans.  Psychosom Med. 1992;  54 123-132
    CrossrefPubMedGoogle Scholar
  • 48 Exton M S, Auer A K von, Buske-Kirschbaum A. et al . Pavlovian conditioning of immune function: Animal investigation and the challenge of human application.  Behav Brain Res. 2000;  110 129-141
    CrossrefPubMedGoogle Scholar
  • 49 Kirschbaum C, Jabaaij L, Buske-Kirschbaum A. et al . Conditioning of drug-induced immunomodulation in human volunteers: A European collaborative study.  Br J Clin Psychol. 1992;  31 459-472
    PubMedGoogle Scholar
  • 50 Hsueh C-M, Chen S-F, Ghanta V K, Hiramoto R N. Expression of the conditioned NK cell activity is β-endorphin dependent.  Brain Res. 1995;  678 76-82
    CrossrefPubMedGoogle Scholar
  • 51 Hsueh C-M, Kuo J-S, Chen S-F. et al . Involvement of catecholamines in recall of the conditioned NK cell response.  J Neuroimmunol. 1999;  94 172-181
    CrossrefPubMedGoogle Scholar
  • 52 Schedlowski M, Falk A, Rohne A. et al . Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells.  J Clin Immunol. 1993;  13 344-351
    CrossrefPubMedGoogle Scholar
  • 53 Exton M S, Hörsten S von, Strubel T. et al . Conditioned alternations of specific blood leukocyte subsets are reconditionable.  Neuroimmunomodulation. 2000;  7 106-114
    CrossrefPubMedGoogle Scholar
  • 54 Stockhorst U, Klosterhalfen S. Klinische Anwendungen der klassischen Konditionierung von Immunfunktionen. In: Schulz K-H, Kugler J, Schedlowski M (Hrsg) Psychoneuroimmunologie. Bern; Huber 1997: 373-388
    Google Scholar
  • 55 Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus.  Science. 1982;  215 1534-1536
    CrossrefPubMedGoogle Scholar
  • 56 Olness K, Ader R. Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus.  J Dev Behav Pediatr. 1992;  13 124-125
    PubMedGoogle Scholar
  • 57 Klosterhalfen W, Klosterhalfen S. Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats.  Behav Neurosci. 1983;  97 663-666
    CrossrefPubMedGoogle Scholar
  • 58 Klosterhalfen S, Klosterhalfen W. Conditioned immunopharmacologic effects and adjuvant arthritis: Further results. In: Spector NH (ed) Neuroimmunomodulation. Proceedings of the First International Workshop on NIM. Bethesda; IWGN 1985: 183-187
    Google Scholar
  • 59 Klosterhalfen S, Klosterhalfen W. Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats.  Behav Neurosci. 1990;  104 716-724
    CrossrefPubMedGoogle Scholar
  • 60 Giang D W, Goodman A D, Schiffer R B. et al . Conditioning of cyclophosphamide-induced leukopenia in humans.  J Neuropsychiatry Clin Neurosci. 1996;  8 194-201
    PubMedGoogle Scholar
  • 61 Gorczynski R M. Conditioned enhancement of skin allografts in mice.  Brain Behav Immun. 1990;  4 85-92
    CrossrefPubMedGoogle Scholar
  • 62 Grochowicz P M, Schedlowski M, Husband A J. et al . Behavioral conditioning prolongs heart allograft survival in rats.  Brain Behav Immun. 1991;  5 349-356
    CrossrefPubMedGoogle Scholar
  • 63 Gorczynski R M, Kennedy M, Ciampi A. Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression.  J Immunol. 1985;  134 4261-4266
    PubMedGoogle Scholar
  • 64 Ghanta V K, Hiramoto R N, Solvason H B, Spector N H. Neural and environmental influences on neoplasia and conditioning of NK activity.  J Immunol. 1985;  135 848s-852s
    PubMedGoogle Scholar
  • 65 Ghanta V, Hiramoto R N, Solvason B, Spector N H. Influence of conditioned natural immunity on tumor growth.  Ann N Y Acad Sci. 1987;  496 637-646
    PubMedGoogle Scholar
  • 66 Ghanta V K, Hiramoto N S, Solvason H B. et al . Conditioning: A new approach to immunotherapy.  Cancer Res. 1990;  50 4295-4299
    PubMedGoogle Scholar
  • 67 Newman M E. Can an immune response be conditioned?.  J Natl Cancer Inst. 1990;  82 1534-1535
    PubMedGoogle Scholar
  • 68 Hiramoto R N, Hiramoto N S, Rish M E. et al . Role of immune cells in the Pavlovian conditioning of specific resistance to cancer.  Int J Neurosci. 1991;  59 101-117
    PubMedGoogle Scholar
  • 69 Stockhorst U, Klosterhalfen S, Klosterhalfen W. et al . Anticipatory nausea in cancer patients receiving chemotherapy: Classical conditioning etiology and therapeutical implications.  Integr Physiol Behav Sci. 1993;  28 177-181
    CrossrefPubMedGoogle Scholar
  • 70 Bernstein I L. Aversion conditioning in response to cancer and cancer treatment.  Clin Psychol Rev. 1991;  11 185-191
    PubMedGoogle Scholar
  • 71 Stockhorst U, Klosterhalfen S, Steingrüber H-J. Conditioned nausea and further side-effects in cancer chemotherapy: A review.  Journal of Psychophysiology. 1998;  12 (Supplement) 14-33
    PubMedGoogle Scholar
  • 72 Bovbjerg D H, Redd W H, Maier L A. et al . Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer.  J Consult Clin Psychol. 1990;  58 153-157
    CrossrefPubMedGoogle Scholar
  • 73 Fredrikson M, Fürst C J, Lekander M. et al . Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.  Brain Behav Immun. 1993;  7 79-90
    CrossrefPubMedGoogle Scholar
  • 74 Lekander M, Fürst C J, Rotstein S. et al . Does informed adjuvant placebo chemotherapy for breast cancer elicit immune changes?.  Oncol Rep. 1994;  1 699-703
    PubMedGoogle Scholar
  • 75 Lekander M, Fürst C J, Rotstein S. et al . Anticipatory immune changes in women treated with chemotherapy for ovarian cancer.  Int J Behav Med. 1995;  2 1-12
    PubMedGoogle Scholar
  • 76 Rosenberg S A. The development of new immunotherapies for the treatment of cancer using interleukin-2.  Ann Surg. 1988;  208 121-135
    PubMedGoogle Scholar
  • 77 Mageed A A, Findley H W, Franco C. et al . Natural killer cells in children with acute leukemia. The effect of interleukin-2.  Cancer. 1987;  60 2913-2918
    PubMedGoogle Scholar
  • 78 Valen F Van, Winkelmann W, Burdach S. et al . Interferon γ and tumour necrosis factor α induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.  J Cancer Res Clin Oncol. 1993;  119 615-621
    CrossrefPubMedGoogle Scholar
  • 79 Bernstein I L. Neural mediation of food aversions and anorexia induced by tumor necrosis factor and tumors.  Neurosci Biobehav Rev. 1996;  20 177-181
    CrossrefPubMedGoogle Scholar
  • 80 Plata-Salamán C R. Brain mechanisms in cytokine-induced anorexia.  Psychoneuroendocrinology. 1999;  24 25-41
    CrossrefPubMedGoogle Scholar
  • 81 Stockhorst U. Klassische Konditionierung bei der Gabe von Pharmaka. Lengerich; Pabst Science Publishers 2003
    Google Scholar
  • 82 Tracey K J. The inflammatory reflex.  Nature. 2002;  420 853-859
    CrossrefPubMedGoogle Scholar
  • 83 Ader R. Conditioned immunomodulation: Research needs and directions.  Brain Behav Immun. 2003;  17 (S1) S51-S57
    CrossrefPubMedGoogle Scholar
  • 84 Steinman L. Elaborate interactions between the immune and nervous systems.  Nature Immunol. 2004;  5 575-581
    PubMedGoogle Scholar
  • 85 Ramírez-Amaya V, Bermúdez-Rattoni F. Conditioned enhancement of antibody production disrupted by insular cortex and amygdala but not hippocampal lesions.  Brain Behav Immun. 1999;  13 46-60
    CrossrefPubMedGoogle Scholar
  • 86 Ramírez-Amaya V, Alvarez-Borda B, Bermúdez-Rattoni F. Differential effects of NMDA-induced lesions into the insular cortex and amygdala on the acquisition and evocation of conditioned immunosuppression.  Brain Behav Immun. 1998;  12 149-160
    CrossrefPubMedGoogle Scholar
  • 87 Seligman M EP, Maier S F. Failure to escape traumatic shock.  J Exp Psychol. 1967;  74 1-9
    PubMedGoogle Scholar
  • 88 Laudenslager M L, Ryan S M, Drugan R C. et al . Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation.  Science. 1983;  221 568-570
    PubMedGoogle Scholar
  • 89 Mormede P, Dantzer R, Michaud B. et al . Influence of stressor predictability and behavioral control on lymphocyte reactivity, antibody responses and neuroendocrine activation in rats.  Physiol Behav. 1988;  43 577-583
    CrossrefPubMedGoogle Scholar
  • 90 Sandi C, Borrell J, Guaza C. Behavioral, neuroendocrine, and immunological outcomes of escapable or inescapable shocks.  Physiol Behav. 1992;  51 651-656
    CrossrefPubMedGoogle Scholar
  • 91 Weisse C S, Pato C N, McAllister C G. et al . Differential effects of controllable and uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans.  Brain Behav Immun. 1990;  4 339-351
    CrossrefPubMedGoogle Scholar
  • 92 Sieber W J, Rodin J, Larson L. et al . Modulation of human natural killer cell activity by exposure to uncontrollable stress.  Brain Behav Immun. 1992;  6 141-156
    CrossrefPubMedGoogle Scholar
  • 93 Persinger M A, Ossenkopp K-P, Kamaya V, Pear J J. Physiological changes associated with changing fixed ratio schedules in rats.  Psychol Rep. 1974;  35 847-850
    PubMedGoogle Scholar
  • 94 Sacerdote P, Manfredi B, Bianchi M, Panerai A E. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat.  Brain Behav Immun. 1994;  8 251-260
    CrossrefPubMedGoogle Scholar

PD Dr. rer. nat. Ursula Stockhorst

Institut für Medizinische Psychologie · Heinrich-Heine-Universität Düsseldorf

Postfach 101007

40001 Düsseldorf

Email: ursula.stockhorst@uni-duesseldorf.de

      >